The emerging field of Immuno-Oncology (I-O) has elicited immense promise in the cancer care paradigm. Profound scientific advancements in the field of cancer immunotherapy have captured the attention of providers and patients alike. Along with this astounding science comes the urgent need to understand the intricacies of this newly adopted treatment.
Immuno-oncology is comprised of distinct features which often present unique response patterns, uncommon within traditional cancer care protocol. To further the understanding of these clinical implications arises the urgent need for comprehensive resources that are accessible and geared toward all members of the cancer care community. The integration of a newly evolved therapy into the community cancer care setting will present challenges well beyond delivery.
ICLIO will address the full spectrum of these challenges, empowering multidisciplinary cancer care teams to successfully implement Immuno-oncology.